Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-25-053130
Filing Date
2025-04-11
Accepted
2025-04-11 13:43:30
Documents
2
Period of Report
2025-04-11

Document Format Files

Seq Description Document Type Size
1 6-K press_release_april_11_2.htm 6-K 24404
2 EX-99.1 ipa-ex99_1.htm EX-99.1 15160
  Complete submission text file 0000950170-25-053130.txt   40618
Mailing Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701
Business Address INDUSTRIOUS, 823 CONGRESS AVE, SUITE 300 AUSTIN TX 78701 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 25830985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)